ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.56
0.59%
After-hours: Aug 15, 2025, 07:58 PM EDT

ImmunityBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-92.56M -129.67M -59.18M -85.75M -134.58M -134.13M -233.39M -95.64M -138.21M -116.58M -108.33M -111.16M -94.83M -103M -91.55M -88.43M -89.39M -80.48M
Depreciation & Amortization
3.88M 3.83M 4.14M 4.44M 4.41M 4.55M 4.56M 4.58M 4.68M 4.68M 5.23M 4.5M 4.44M 4.09M 3.6M 3.69M 3.98M 2.97M
Stock-Based Compensation
9.65M 9.54M 9.04M 7.49M 9.64M 8.27M 12.77M 14.45M 11.06M 10.88M 9.35M 10.63M 10.18M 10.02M 10.18M 13.84M 17.86M 15.3M
Other Working Capital
3.96M -13.63M -3.13M 2.16M 708K -8.21M -22.87M -4.27M 10.6M 27M -7.03M 10.25M 1.66M 8.82M -3.24M -9.16M -1.99M -1.01M
Other Non-Cash Items
14.48M 52.43M -28.3M -23.47M 14.83M 18.22M 151.31M 9.9M 23.23M -10.96M 9.62M 4.15M 4.19M 4.34M 12.93M 4.09M 3.53M 4.87M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -24.78M -13.69M 10.41M n/a -4K n/a n/a n/a -8K 6.02M 293K -8.61M
Change in Working Capital
-5.55M -22.04M -10.84M -1.47M 5.36M -3.89M -25.75M -7M 9.06M 27.67M -6.59M 11.28M -18.4M 9.61M -6.79M -11.93M -5.88M 5.49M
Operating Cash Flow
-79.75M -85.91M -85.14M -98.76M -100.35M -106.98M -115.27M -87.4M -79.77M -84.31M -90.73M -80.6M -91.25M -74.93M -71.64M -72.72M -69.59M -60.47M
Capital Expenditures
-1.08M -1.12M -2.11M -2.79M -724K -1.26M -7.96M -5.67M -8.53M -8.43M -18.93M -15.94M -15.95M -48.58M -10.4M -8.03M -8.04M -7.08M
Cash Acquisitions
n/a n/a n/a -1M n/a n/a -10.2M n/a n/a 56K 1M -14.77M n/a -1M n/a 20.5M n/a n/a
Purchase of Investments
-15.06M -100K -6.09M -747K -85.77M -48.36M -166K -9.96M -78K -158K -19K -86K -125K -34.08M -139M -2.48M -175K -91K
Sales Maturities Of Investments
n/a 5.35M 18.03M 69.57M 35M 14M 10.37M n/a n/a 102K 56K 14.85M 132.75M 14.35M 11.6M 599K 18.71M 39.02M
Other Investing Acitivies
n/a n/a n/a n/a n/a -34.36M 10.2M -9.96M -78K -56K -1M 14.77M 132.62M -41.97M -127.4M 20.5M 18.53M 38.93M
Investing Cash Flow
-16.14M 4.13M 9.83M 65.03M -51.49M -35.62M 2.25M -15.63M -8.6M -8.48M -18.89M -1.17M 116.67M -69.31M -137.8M 10.58M 10.49M 31.84M
Debt Repayment
-4K n/a 64K -22K -21K -21K 192.74M 198.98M 29.83M 29.83M 49.73M 124.33M n/a n/a 298.5M n/a n/a 40M
Common Stock Repurchased
n/a n/a n/a n/a n/a -3.87M n/a n/a n/a n/a n/a -10K -15K -372K n/a n/a n/a -2.62M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-322K -1.2M -867K -299K 145.29M 10.25M -1.56M -1.43M 75K -231K -219K -349K -15K -298K -129K 734K 98.34M -1.5M
Financial Cash Flow
172.81M -982K 106.93M 15.58M 148.89M 10.22M 200.54M 237.5M 43.41M 76.89M 109.94M 123.99M -15K -298K 325.95M 42.66M 98.34M 38.5M
Net Cash Flow
77M -82.77M 31.61M -18.14M -2.93M -132.42M 87.49M 134.47M -44.98M -16.16M 480K 42.26M 25.66M -144.72M 116.58M -19.43M 39.28M 9.76M
Free Cash Flow
-80.83M -87.03M -87.25M -101.56M -101.07M -108.24M -123.23M -93.08M -88.3M -92.74M -109.66M -96.53M -107.2M -123.51M -82.04M -80.75M -77.64M -67.55M